IS6491A
Pteridine compounds for the treatment of psoriasis
Abstract
The invention provides pteridine compounds of formula (I), processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy. Formula (I) in which A is a group of formula (a) or (b).
Term
Term ended
Projected expiry passed 7 August 2022, 4.1 years ago.
- Priority
- Filed and published
- Projected expiry
- Today
51 members in 34 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 0004128 | United Kingdom | A | |
| 0004128 | United Kingdom | A | |
| 0100374 | Sweden | W | |
| 0100374 | Sweden | W | |
| GB00041285A | – | – | – |
| GB20000004128 | – | – | – |
| PCTSE0100374 | – | – | – |
| WO2001SE00374 | – | – | – |
Members51
| Document | Office | Kind | |
|---|---|---|---|
| GB0004128D0 | United Kingdom | D0 | |
| GB2359551A | United Kingdom | A | |
| CA2400217A1 | Canada | A1 | |
| WO0162758A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3431601A | Australia | A | |
| IS6491AThis record | Iceland | A | |
| NO20024005D0 | Norway | D0 | |
| NO20024005L | Norway | L | |
| BR0108600A | Brazil | A | |
| CZ20022839A3 | Czechia | A3 | |
| EP1259512A1 | European Patent Office (EPO) | A1 | |
| KR20030005207A | Republic of Korea | A | |
| SK12152002A3 | Slovakia | A3 | |
| CN1404482A | China | A | |
| US2003055250A1 | United States of America | A1 | |
| IL151132D0 | Israel | D0 | |
| BG107002A | Bulgaria | A | |
| HU0204399A2 | Hungary | A2 | |
| HUP0204399A2 | Hungary | A2 | |
| CO5290258A1 | Colombia | A1 | |
| HK1050899A1 | Hong Kong, China | A1 | |
| AR029805A1 | Argentina | A1 | |
| JP2003524012A | Japan | A | |
| EP1259512B1 | European Patent Office (EPO) | B1 | |
| AT250605T | Austria | T | |
| ATE250605T1 | Austria | T1 | |
| DE60100851D1 | Germany | D1 | |
| ZA200206590B | South Africa | B | |
| EE200200461A | Estonia | A | |
| DK1259512T3 | Denmark | T3 | |
| RU2002125451A | Russian Federation | A | |
| TR200302214T4 | Türkiye | T4 | |
| PT1259512E | Portugal | E | |
| SI1259512T1 | Slovenia | T1 | |
| MXPA02008233A | Mexico | A | |
| ES2206402T3 | Spain | T3 | |
| DE60100851T2 | Germany | T2 | |
| PL358004A1 | Poland | A1 | |
| HU0204399A3 | Hungary | A3 | |
| HUP0204399A3 | Hungary | A3 | |
| NZ520355A | New Zealand | A | |
| CN1190437C | China | C | |
| UA72590C2 | Ukraine | C2 | |
| US6875868B2 | United States of America | B2 | |
| AU782509B2 | Australia | B2 | |
| US2005171345A1 | United States of America | A1 | |
| KR100795758B1 | Republic of Korea | B1 | |
| CA2400217C | Canada | C | |
| US7579342B2 | United States of America | B2 | |
| IL151132A | Israel | A | |
| NO329898B1 | Norway | B1 |
Numbers
- Publication, DOCDB
- 6491
- Publication, EPODOC
- IS6491
- Application
- 6491
- Application, DOCDB
- 6491
- Application, EPODOC
- IS20020006491
Titles2
- Icelandic
- Pteridínefnasambönd til meðhöndlunar á sóríasis
- English
- Pteridine compounds for the treatment of psoriasis
Classification
- CPC, 23
- C07D513/04
- A61P1/00
- C07D453/02
- A61P7/00
- C07D475/06
- A61P9/10
- A61P11/06
- A61P17/00
- A61P17/06
- A61P19/02
- A61P25/00
- A61P25/04
- A61P25/16
- A61P25/22
- A61P25/24
- A61P25/28
- A61P25/34
- A61P29/00
- A61P35/00
- A61P37/02
- A61P37/08
- A61P43/00
- A61K31/519
- IPC, 29
- A61K31 439
- A61K31 4427
- A61K31 4709
- C07D487 08
- A61K31 519
- A61K31 5377
- A61K31 542
- A61P1 00
- A61P7 00
- A61P9 10
- A61P11 06
- A61P17 06
- A61P19 02
- A61P25 00
- A61P25 04
- A61P25 16
- A61P25 22
- A61P25 24
- A61P25 28
- A61P25 34
- A61P29 00
- A61P37 02
- A61P37 08
- A61P43 00
- C07D453 02
- C07D453 06
- C07D475 00
- C07D475 06
- C07D513 04